Mukka Proteins Gains 4.92%: 2 Key Factors Driving the Weekly Recovery

Apr 04 2026 10:02 AM IST

Share Via

Mukka Proteins Ltd experienced a volatile week, ultimately closing with a 4.92% gain from Rs.19.71 to Rs.20.68, outperforming the Sensex which declined by 0.29% over the same period. The stock’s trajectory was marked by a sharp fall to an all-time low on 30 March, followed by a robust rebound in the subsequent sessions, reflecting mixed investor sentiment amid ongoing fundamental challenges.

Key Events This Week

30 Mar: Stock hits all-time low at Rs.18.44 amid prolonged downtrend

01 Apr: Sharp recovery with a 9.79% gain to Rs.20.19

02 Apr: Continued upward momentum, closing at Rs.20.68 (+2.43%)

03 Apr: No trading data available; week closes at Rs.20.68

Week Open

Rs.19.71

Week Close

Rs.20.68

+4.92%

Week High

Rs.20.68

vs Sensex

+5.21%

30 March 2026: All-Time Low Amid Prolonged Downtrend

On 30 March, Mukka Proteins Ltd’s stock plunged to an all-time low of Rs.18.44, closing at Rs.18.39, down 6.70% on the day. This marked a significant milestone in the company’s extended period of decline, with the stock underperforming the Sensex’s 2.29% drop by a wide margin. The intraday low breached previous 52-week lows, signalling sustained bearish momentum.

The stock’s fall was accompanied by a notable increase in delivery volumes, rising 126.24% compared to the 5-day average, indicating heightened trading activity amid the sell-off. Institutional investors have reduced their holdings to 1.86%, down 1.5% from the previous quarter, reflecting diminished confidence in the company’s near-term prospects.

Fundamentally, Mukka Proteins continues to face challenges with a negative five-year CAGR of -4.98% in operating profits and a high debt-to-EBITDA ratio of 5.26 times. The company’s return on capital employed remains modest at 9.16%, while interest coverage ratios and leverage metrics highlight financial constraints. Despite these headwinds, the company reported improved quarterly results in December 2025, with net sales reaching Rs.653.50 crores and PAT doubling to Rs.23.75 crores compared to the prior four-quarter average.

1 April 2026: Sharp Rebound with 9.79% Gain

Following the steep decline, Mukka Proteins Ltd staged a strong recovery on 1 April, surging 9.79% to close at Rs.20.19. This rebound outpaced the Sensex’s 1.97% gain, signalling renewed buying interest. The recovery was likely supported by the company’s recent quarterly performance, which showed operational improvements despite ongoing financial pressures.

Technical indicators remained mixed but showed signs of short-term bullishness. The stock’s price moved above the immediate support level of Rs.20.20, which had acted as a floor during the prior downtrend. However, resistance levels at Rs.21.64 (20-day moving average) and Rs.23.59 (100-day moving average) remain key hurdles for sustained upside momentum.

2 April 2026: Continued Uptrend with Moderate Gains

Mukka Proteins Ltd extended its upward momentum on 2 April, closing at Rs.20.68, up 2.43%. The stock outperformed the Sensex, which was nearly flat with a 0.08% gain. Volume was lower compared to earlier in the week, suggesting cautious optimism among investors.

The stock’s technical profile showed some improvement, with the Relative Strength Index (RSI) indicating mild bullishness on a monthly basis, though weekly momentum remained subdued. The Moving Average Convergence Divergence (MACD) indicator continued to signal bearishness on the weekly chart, reflecting the stock’s longer-term challenges.

Weekly Price Performance: Mukka Proteins Ltd vs Sensex

Date	Stock Price	Day Change	Sensex	Day Change
2026-03-30	Rs.18.39	-6.70%	32,182.38	-2.29%
2026-04-01	Rs.20.19	+9.79%	32,814.97	+1.97%
2026-04-02	Rs.20.68	+2.43%	32,839.65	+0.08%

Key Takeaways

Positive Signals: The stock’s sharp rebound from an all-time low and subsequent gains of 4.92% for the week demonstrate resilience amid a challenging environment. Improved quarterly results with record net sales and doubled PAT in December 2025 provide some operational support. The stock’s valuation metrics, including a P/E of 13x and EV to capital employed ratio of 1.15x, suggest it trades at a discount relative to peers.

Cautionary Factors: Mukka Proteins continues to face significant headwinds, including a negative five-year EBIT growth rate of -4.98%, high leverage with a debt-to-EBITDA ratio of 5.26 times, and modest profitability with ROCE around 9.16%. Institutional investor participation remains low and declining, reflecting cautious sentiment. Technical indicators largely remain bearish, with key resistance levels yet to be breached for a sustained uptrend.

Conclusion

Mukka Proteins Ltd’s week was characterised by a dramatic fall to an all-time low followed by a notable recovery, resulting in a net weekly gain of 4.92% that outperformed the Sensex’s decline of 0.29%. While the rebound reflects some short-term optimism, the company’s fundamental challenges and bearish technical signals suggest that the stock remains under pressure. Investors should continue to monitor the company’s financial health, leverage, and sector dynamics as it navigates this volatile phase.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE